Vertical: CNMBase Year: 201711 Sections
Market Size (2017)
$2.43B
Projected (2023)
$3.19B
CAGR (2015–2023)
4.5%
Key Players
10+
Scale inhibitors are chemical materials used to control or prevent scale deposition in the production conduit or completion system. They may be continuously injected through a downhole injection point or periodic squeeze treatments may be undertaken to place the inhibitor in the reservoir matrix for subsequent blending with produced fluids. Some of the most commonly occurring scales include calcium carbonate, barium sulfate, calcium sulfate, and zinc sulfide, which result in heat loss in equipment such as heat exchangers, boilers, and process piping lines. Phosphonates, sulfonates, and carboxylate/acrylate are some of the most preferred scale inhibitors used across an array of industries to prevent scale formation in heat transfer equipment and process pipelines.
The primary market demand drivers of scale inhibitors include the increasing demand for scale inhibitors in the energy sector, which is an important area for investment and growth. The energy sector requires large volumes of treated water, especially in power plants. Moreover, the hydraulic fracturing boom has led to an increased demand for water treatment chemicals in the oil & gas industry. Scale inhibitors play a prominent role in the oil & gas industry as the water used needs to be chemically treated with scale inhibitors, such as phosphonates, to reduce or check scale formation on machinery and equipment in production wells, water and disposal wells, flow lines, and surface equipment. Also, rapid industrialization and urbanization in emerging economies have led to the rising demand for water treatment chemicals owing to the implementation of stringent norms. The need to prevent industrial assets from developing scale and corrosion has resulted in the increased consumption of water treatment chemicals such as scale inhibitors, corrosion inhibitors, and biocides. Increasing investments by governments in improving sewer infrastructure are also expected to drive the growth of the market. Moreover, the increasing construction of industrial facilities and institutions such as schools, hospitals, and shopping malls necessitates water treatment, thereby, driving the growth of the scale inhibitors market.
Furthermore, increasing demand for sustainable chemicals is a noted trend in the market; with growing scrutiny on the impact of chemical discharge on the environment numerous biodegradable scale inhibitor formulations, based on biodegradable carboxylic acid, have been developed recently. These environmentally friendly products offer good scale-inhibition performance in various equipment. Increasing research and development of new-generation environmentally friendly scale inhibitors is expected to drive market growth during the forecast period. For instance, researchers have found that in downhole oil wells, ascorbic acid, a biodegradable natural product, inhibits calcium carbonate scale deposition. Therefore, in sensitive marine environments, ascorbic acid is used as an excellent green chemical for continuous injection into the wellbore to prevent carbonate scale formation.
However, the industry faces challenges with volatility in raw material prices and environmental regulations. The majority of scale inhibitors are petroleum-based; hence, the fluctuating prices of crude oil are impacting the price of scale inhibitors. With these fluctuations, manufacturers are struggling to maintain profit margins. Moreover, increasing research and development in biodegradable scale inhibitors and stringent regulations regarding the use of non-biodegradable scale inhibitors in certain end-use applications are expected to hamper market growth during the forecast period. Stringent regulatory standards imposed by government agencies on the use of petrochemical-derived products limit the use of petroleum-based scale inhibitors. However, key industry players are adopting sustainable and compliant manufacturing techniques to meet these regulatory standards.
· Increasing demand for scale inhibitors in the energy sector and water treatment industry
· Rising demand for water treatment additives in developing countries
· Growing demand for biodegradable and efficient scale inhibitors
Key Opportunities and Trends
· Increasing investments in exploration and production of oil & gas
· Water scarcity and focus on energy efficiency
Key Vendors
· BASF SE
· Kemira
· Akzo Nobel N.V.
The Scale Inhibitors Market market is projected to grow at a CAGR of 4.5% from 2015 to 2023.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansScale inhibitors are chemical materials used to control or prevent scale deposition in the production conduit or completion system. They may be continuously injected through a downhole injection point or periodic squeeze treatments may be undertaken to place the inhibitor in the reservoir matrix for subsequent blending with produced fluids. Scale inhibitors are extensively used in various industries such as power, mining, oil & gas, petrochemicals, paper mills, and various environmental protection industries. The amount of scale precipitate formation depends mainly on the temperature, operational pressure, water incongruity, and mineral content in the water.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansResearch Process
Wantstats analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research
Primary Research
Extensive primary research was conducted to gain a deeper insight into the market and the industry performance. For this particular report, we have conducted primary surveys (interviews) with the key level executives (VPs, CEOs, marketing directors, and business development managers, among others) of the major players active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed over the next five to 10 years.
Secondary Research
Secondary research was conducted to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the scale inhibitors market. It was also used to obtain key information about major players, market classification and segmentation according to industry trends, regional markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, international organizations of chemical manufacturers, and paid databases
Market Size Estimation
Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets of the overall scale inhibitors market. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis by Wantstats added before being presented in this report. The following figure shows an illustrative representation of the overall market size estimation process employed for the purpose of this study.
Base Year
2017
Historical Period
2015 – 2016
Forecast Period
2018 – 2023
Primary Interviews
150+
Historical data (2015–2017) and forecast period (2017–2023)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThe prominent players in the global scale inhibitors market are Clariant, Arkema SA, DowDuPont, BASF SE, Ecolab Kemira Oyj, SUEZ, BWA Water Additives, Solenis, and American Water Chemicals, Inc.
BASF SE, DowDuPont, Ecolab, Kemira Oyj, Solenis, and Arkema SA collectively hold the majority share of the global scale inhibitors market. The market players are focused on product innovation and strategic initiatives, such as acquisitions and agreements, to meet the increasing demand for scale inhibitors from various end-use industries such as power and oil & gas and expand their global footprint.
DowDuPont, a leading specialty chemicals producer, provides a wide range of scale inhibitors and antiscalants. The company has 534 manufacturing sites and operates through three business segments—material science, specialty products, and agriculture. The company is focused on developing new solutions for the oil & gas industry. For instance, in 2017, the company showcased its antiscalant products for extreme high-temperature reservoirs and Accent scale inhibitors at the Abu Dhabi International Petroleum Exhibition and Conference (ADIPEC).
BASF SE is one of the largest chemicals producers in the world. The company operates through five business segments—chemicals, performance products, functional materials and solutions, agricultural solutions, and oil & gas. It offers scale inhibitors and antiscalants for oilfield solutions and the water treatment industry. In 2018, the company signed an agreement with Solenis to combine their paper and water chemical businesses to create a customer-focused global specialty chemicals company.
Ecolab is a leading provider of water, hygiene, and energy technologies and services. The company operates through four segments—global industrial, global institutional, global energy, and others. The company offers scale inhibitors through NALCO water, an operating division of the global industrial segment. Ecolab delivers products and services across 170 countries. In 2018, the company sold its phosphonate component business in China, which it acquired in 2015, to Italmatch Chemicals S.p.A.
Kemira Oyj is a global chemicals company engaged in the development and manufacture of products and solutions for the water-intensive chemicals industry. In 2017, the company merged its municipal and industrial and oil and mining segments into a new segment called industry and water. The company also operates through the pulp and paper segment. The company offers scale inhibitors under the brand name KemGuard for various applications which includes heap leach systems, filtration systems, and mining. It delivers the products in around 100 countries globally.
Arkema SA is a manufacturer and supplier of chemical products. It operates through three segments—high performance materials, industrial specialties, and coating solutions. The company has a presence in 55 countries and operates through 136 production centers in Europe, North America, and Asia as well as subsidiaries and sales offices in a large number of countries. The company offers scale inhibitors and antiscalants under its industrial specialties segment for numerous industries, including oil & gas, water treatment, detergent, and consumer goods.
Solenis, formerly known as Ashland Water Technologies, is a subsidiary of Clayton, Dubilier & Rice (CD&R). Solenis is a leading manufacturer of specialty chemicals for various end-use industries and operates 30 manufacturing sites in around 118 countries. The company is focused on business expansion in developing economies. For instance, in 2018, the company opened a new manufacturing site in Zhuhai, China, which will operate various product lines including functional, water, and processing chemicals. This step has been taken to serve customers in Asia-Pacific.
Threat of New Entrants
A medium to low threat of new entrants is expected owing to the high capital-intensive nature of the market. The need for significant expenditure on research and development acts as a barrier for new entrants in the industry. There are also strict environmental policies in developed regions that place the economic burden on the manufacturer to comply with the stringent norms. Moreover, the market demands persistent product and process innovation along with efficient feedstock integration. The established companies in this sector have invested heavily in their production facilities. Alliances between regional players and big compounders to lower manufacturing costs are prevalent in the market. However, the rising demand for high-quality scale inhibitors in numerous end-use industries is expected to provide lucrative opportunities to new entrants during the assessment period.
Threat of Rivalry
The global scale inhibitors market is projected to witness a high threat of rivalry, as each tier-1 player operating in this market has extended portfolios for various types of scale inhibitors and is dedicated to offering quality products to end-use industries. Rivalry among firms has increased as more companies are competing for the same customers and resources. Furthermore, certain prominent manufacturers have established brands in the market. Some of the companies are focusing on improving operational control through digital technology., For instance, Ecolab’s 3D TRASAR technology helps provide remote services and sophisticated monitoring and control to improve a wide range of industrial operations. The diverse operations and differing cost structures of large and small firms are also expected to increase internal rivalry and lead to price wars in the global scale inhibitors market.
Moreover, companies such as SUEZ, Ecolab, Solenis, Kemira Oyj, Arkema SA, and BASF SE are focusing on expanding their reach by opening new manufacturing bases in different locations to mitigate the threat of rivalry.
Threat of Substitutes
The threat of substitutes in the scale inhibitors market is moderate to low at present. In the water treatment industry, there is no threat of substitution as there is no alternative for scale inhibitors. However, biodegradable scale inhibitors are increasingly replacing conventional scale inhibitors as they are environmentally friendly.
Bargaining Power of Suppliers
The bargaining power of suppliers is projected to be low in the global scale inhibitors market. There are several small firms in the market in various countries in Asia-Pacific that offer a variety of differentiated products. On account of the wide applicability of scale inhibitors in every sphere, there is great demand. The market is dominated by players such as SUEZ, Ecolab, Solenis, Kemira Oyj, Arkema SA, BASF SE, DowDuPont, American Water Chemicals, Inc., Clariant, and BWA WATER ADDITIVES. However, there are a few established firms manufacturing biodegradable scale inhibitors. The switching cost from one supplier of biodegradable inhibitors to another is moderate.
Bargaining Power of Buyers
The bargaining power of buyers is estimated to be moderate to high as more choices are available in the market. However, it depends on the nature of the application and choice of product quality. The power, petrochemicals, and oil & gas industries account for a larger share of the market as compared to papermills and others due to the scale of operations in these industries. For high-cost and good-quality scale inhibitors, consumers do not have many choices between which they can switch.
Market estimates by geography (2023)
InsightAsia Pacific leads with $1.50B by 2023, while Middle East and Africa is projected to grow fastest at a 5.4% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2015 | 2017 | 2023 | CAGR | SHARE |
|---|---|---|---|---|---|
| Middle East and Africa | $189.30M | $230.70M | $289.10M | 5.4% | 9% |
| North America | $450.40M | $514.60M | $604.30M | 3.7% | 19% |
| Asia Pacific | $996.80M | $1.20B | $1.50B | 5.2% | 47% |
| Europe | $469.70M | $522.10M | $596.60M | 3.0% | 19% |
| South America | $141.60M | $169.70M | $209.10M | 5.0% | 7% |
| Total | $2.25B | $2.64B | $3.19B | 4.5% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$3.19B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Power | $843.70M | 4.4% | 26% |
| Oil & Gas | $785.20M | 4.6% | 25% |
| Petrochemicals | $451.90M | 5.0% | 14% |
| Mining | $441.80M | 3.7% | 14% |
| Application_Others | $433.60M | 4.9% | 14% |
| Paper Mills | $238.90M | 4.4% | 7% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.
Analytical insights on Scale Inhibitors Market covering market dynamics, competitive landscape, and strategic outlook.
The Scale Inhibitors Market market is projected to reach $3.19B by 2023, growing at 4.5% CAGR. The Power segment holds the largest share.
Introduction
The global scale inhibitors market is expected to grow at a healthy CAGR of 4.68% during the forecast period. The prominent growth of the water treatment industry and the increasing use of scale inhibitors to extend the service life of equipment are driving the growth of the scale inhibitors market. The use of scale inhibitors in the oil & gas industry results in increased production flows, reduced downtime for mechanical, acid, and chemical cleanout, and decreased risk of unscheduled equipment shutdowns. Rapid urbanization and industrialization in China, India, Brazil, and Mexico have necessitated the treatment of wastewater which, in turn, is expected to drive the demand for scale inhibitors during the forecast period. Increasing environmental awareness in developing countries and rising expenditure on research and development, are expected to drive the growth of the market during the forecast period.
The water treatment industry is among the largest and fastest-growing end-use application segments of the scale inhibitors market. Water treatment chemicals are increasingly in demand in industrial operations. The need for zero discharge of industrial water has led to the adoption of reverse osmosis (RO) membranes and other processes to enable plants to reuse and recycle water. RO membranes are used in industrial and municipal water treatment and for the pretreatment of water for boilers and cooling towers. This is expected to lead to the increased use of scale inhibitors in water treatment plants.
In developed regions, such as North America, the energy sector is an important area for investment and growth. The energy sector requires large volumes of treated water, especially in power plants. Moreover, the hydraulic fracturing boom has led to increased demand for water treatment chemicals in the oil & gas industry. Scale inhibitors play a prominent role in the oil & gas industry as the water used needs to be chemically treated with scale inhibitors, such as phosphonates, to reduce or check scale formation on machinery and equipment in production wells, water and disposal wells, flowlines, and surface equipment.
Therefore, the increasing use of scale inhibitors in the energy sector and the water treatment industry is expected to drive market growth during the forecast period.
The substantial economic growth in Brazil and Mexico and the demand for electricity has led to increased offshore oil &gas exploration and production. The demand for petroleum products is predicted to grow significantly in the coming years which, in turn, has raised the need for oil production. Increasing oil & gas production and mining activities in developing countries are expected to drive the growth of the market during the assessment period. The increasing number of vehicles on road has led to a rise in the daily energy demand across the globe. The growing goods and passenger transportation industry due to globalization and increased international trade has augmented fuel demand in the past few years and is projected to positively affect the growth of the market during the review period. Rising energy demand in emerging countries in Latin America and Asia-Pacific, owing to industrialization, is estimated to support offshore drilling and ultimately raise the demand for scale inhibitors. Technological advancements and rising investments in infrastructure are expected to drive oilfield drilling activities during the review period which will have a positive impact on the scale inhibitors market. Rising investments in deep water and ultra-deep water exploration in the South China Sea and the presence of large oil reserves in the Gulf of Mexico have also led to increased exploration activities, which is expected to drive market growth.
Most scale inhibitors are petroleum-based; hence, the fluctuating prices of crude oil are impacting the price of scale inhibitors. With these fluctuations, manufacturers are struggling to maintain profit margins. Moreover, increasing research and development in biodegradable scale inhibitors and stringent regulations regarding the use of non-biodegradable scale inhibitors in certain end-use applications are expected to hamper market growth during the forecast period. Stringent regulatory standards imposed by government agencies on the use of petrochemical-derived products limit the use of petroleum-based scale inhibitors. However, key industry players are adopting sustainable and compliant manufacturing techniques to meet these regulatory standards.
The need to reduce energy costs in industrial operations has led to companies reusing water for different purposes. In dry regions, such as the Middle East & Africa, the severe water scarcity has led policymakers to explore unconventional water resources, such as recycled wastewater. The increasing demand for fresh water has augmented the growth of the RO membrane water treatment market which is likely to boost the demand for scale inhibitors. Moreover, increased pressure on the world’s water resources, driven by population growth and climate change, has resulted in the pressing need for wastewater treatment, which, in turn, is expected to drive the demand for scale inhibitors during the assessment period.
The growth of the oil & gas industry worldwide has led to the extensive use of scale inhibitors. Pipelines needed for the transportation of oil & gas from rigs to refineries should be of the highest quality in order to prevent the spillage of crude oil. Scale formation on the surfaces of these pipelines weakens the pipes leading to cracks on the surfaces. To avoid this situation scale inhibitors are used to maintain the quality of pipes, which helps extend the lifecycle of equipment, thereby, increasing energy efficiency.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 109 companies operating in the Scale Inhibitors Market market, including revenue, employee count, and market positioning where available.
Showing 109 of 109 companies
Company Headquarters: Colombes, France Founded: 2003 Workforce: ~20,000 Company Working: Arkema is engaged in the manufacturing and supply of specialty chemicals and advanced materials. It operates through three segments: high-performance materials, industrials specialties, and coating solutions. The company offers value-added solutions to various markets including construction, electronics and electrical, food, agrochemicals, oil and gas, packaging and paper, renewable energies, transportation, water, health, hygiene, beauty, and sports. Hydrate inhibitors are offered under the industrial specialties segment. Arkema has 136 production sites and 15 research centers, with six R&D centers dedicated to sustainable development, in 55 countries across the globe.
Ecolab is the world's largest pure-play provider of water treatment, hygiene and infection-prevention solutions. It sells mission-critical chemistry, dispensing and monitoring equipment, digital analytics and on-site service, mostly under recurring, programme-based customer relationships. FY2025 net sales were $16.08bn. The mix by segment was: - Global Water: about 49% - Global Institutional & Specialty: about 38% - Global Pest Elimination: about 8% - Global Life Sciences: about 5% The company says it helps protect about one-third of the world's food production and about a quarter of global power generation. Under CEO Christophe Beck, Ecolab is moving its portfolio toward higher-growth, higher-margin "growth engines": Global High-Tech, Life Sciences, Pest Elimination and Ecolab Digital. The pivot accelerated in 2025–26 with two acquisitions: - Ovivo Electronics (ultrapure water for semiconductor fabs) - CoolIT Systems (direct-to-chip liquid cooling for AI data centres) Together these make Ecolab a full-stack "water-for-AI" supplier. The equity is valued as a quality compounder at about 34x 2026 adjusted EPS. The investment case rests on 12–15% EPS growth with margins above 20%. --- ### Company's own description (paraphrased from the FY2025 10-K and 2026 releases) Ecolab describes itself as a global leader in water, hygiene and infection-prevention solutions and services that protect people and vital resources. It says it combines science-based solutions, data-driven insights, AI technology and on-site service so that customers can define best-in-class operations and scale them across sites. The company lists its served markets as food, hospitality, healthcare, data centres, microelectronics, life sciences and heavy industry. It positions itself as "the world's water company" in the AI value chain, with three roles: - ultrapure water for chip fabrication - water treatment for the power plants that supply AI - direct liquid cooling for high-density compute Its 2030 impact goals are to help protect 2 billion people from infections and to conserve enough drinking water for 1 billion people (Q2-2026 release, "About Ecolab"). ### Business model and revenue model Ecolab's model is a razor/razor-blade service model with three layers: 1. **Consumable chemistry.** Detergents, sanitisers, water-treatment chemicals, process aids, pest products and purification resins. These are replenished continuously and drive most revenue and gross profit. 2. **Equipment.** Dispensers, controllers, sensors and liquid-cooling hardware. These are often placed at customer sites under lease or service arrangements, which creates switching costs. 3. **Field service and digital.** The 25,000-plus sales-and-service workforce audits, optimises and documents outcomes such as water saved, energy saved and regulatory compliance. Ecolab Digital (software and enabling hardware subscriptions) is a fast-growing overlay. **Revenue mix (FY2025, from the income statement in the 10-K and the Q4-2025 release):** **Characterisation of the mix:** - About 78% of revenue is product and equipment, though much of it is contractually recurring. - About 22% is service and lease. - Subscription revenue is a small but fast-growing slice. Ecolab Digital sales were $121m in Q2-2026, up 27% (8-K, 28 Jul 2026), implying a run-rate of roughly $0.45–0.5bn. - Licensing is not material. - The single largest product class is warewashing, at about 13% of FY2025 consolidated sales (10-K FY2025). ### Value-chain position Ecolab sits downstream of commodity and specialty chemical producers. Its main inputs are: - caustic soda, surfactants, phosphonates and polymers - solvents and resins - energy and plastics packaging It formulates, packages and distributes its products. It then captures margin through application know-how and service rather than molecule ownership. Pricing power comes from three sources: - customer total-cost-of-operation savings, which Ecolab quantifies as "value pricing" - the low cost of chemistry relative to the customer processes it protects (food safety, uptime, compliance) - embedded equipment and digital monitoring The 2026 energy surcharge shows both the pass-through ability and its lag. Organic gross margin dipped in early 2026 and then stabilised within one quarter (Q2-2026 release). ### Customer types and end-markets ### Independent characterisation Ecolab is best understood as a service-intensive specialty-chemicals compounder with three core features: - a defensive base: hospitality, food safety and healthcare hygiene, about 45% of sales - a cyclical but sticky industrial water franchise (Nalco, acquired 2011) - a set of secular-growth options FY2025 organic growth was about 3%. The company's long-term algorithm is 5–7% organic growth, 100–150 bps of annual operating-margin expansion, and 12–15% adjusted EPS growth. The 2026 acquisitions deliberately raise exposure to AI capital-expenditure cycles. That improves the growth mix but adds cyclicality and technology risk not historically present in the franchise.
Company Headquarters: Paris, France Founded: 1858 Workforce: ~88,775 Company Working: SUEZ specializes in providing water and waste management products and services. The company operates through five business segments, namely water Europe; recycling & recovery Europe; international; water technologies & solutions (WTS); and others. It offers chemicals, equipment, services (water distribution & treatment, and consulting), and engineering and construction contracts. Coagulants are offered under the water technologies & solutions business segment for applications such as industrial waste streams and influent clarification systems. It has operations in Europe and internationally.
Kemira is a Helsinki-headquartered, mid-cap specialty and commodity-adjacent chemicals producer that describes itself as a global leader in sustainable chemistry for water-intensive industries. With FY2025 revenue of EUR 2,753.5M and operative EBITDA of EUR 524.6M (19.1% margin), it is among the world's largest suppliers of water-treatment coagulants and polyacrylamide polymers. It is also a leading supplier of pulp bleaching chemicals (sodium chlorate, hydrogen peroxide) and of process and functional chemicals for packaging board, tissue and paper. After divesting Oil & Gas in February 2024, Kemira reorganised into three business units on 1 January 2025: Water Solutions (≈44% of revenue), Packaging & Hygiene Solutions (≈35%) and Fiber Essentials (≈20%). Its strategic ambition is to double water-related revenue, including a 2025 entry into US industrial water-treatment services. It also pursues EUR 500M+ of renewable-solutions revenue by 2030. The company is financially conservative (net debt/operative EBITDA 1.0x at end-2025) and is anchored by Oras Invest. In 2026 it is navigating a sharp, Iran-war-driven raw material and logistics cost shock. --- ### Company self-description (latest annual reporting, FY2025) Kemira presents itself as a global leader in sustainable chemistry for water-intensive industries. It serves municipal and industrial water-treatment customers and the fiber industry. Its solutions are positioned around securing clean water and supporting customers' circularity and resource-efficiency goals across their value chains. Its strategic pillars (as communicated since the 2024 strategy update) are profitable growth, with water as the principal growth engine, and renewable (bio-based) solutions as a long-term differentiation axis. ### Independent characterisation Kemira is best understood as a process-chemicals manufacturer with a "local-for-local" asset base. It operates 58 manufacturing facilities globally (FY2025 Board of Directors' Review). Its products are high-volume, relatively low-value-per-tonne chemicals (iron- and aluminium-based coagulants, sodium chlorate, hydrogen peroxide, caustic soda) where freight costs make proximity to customers a structural moat. These sit alongside higher-value functional chemistries (polyacrylamide flocculants, sizing agents such as AKD wax, dry- and wet-strength resins, defoamers, biocides, barrier chemistries). Value is added through application know-how, on-site service and, increasingly, digital dosing optimisation. The company's revenue model is overwhelmingly product sales under supply contracts. Water Solutions' municipal business is dominated by tendered, often fixed-price contracts, which explains the lag in passing through cost inflation highlighted in Q2 2026. Fiber Essentials sells bleaching chemicals under long-term agreements to pulp mills, in some cases from chemical "islands" co-located with customer mills. A nascent services revenue stream has been created through the acquisitions of Water Engineering, Inc. (October 2025), AquaBlue, Inc. (January 2026) and the Clear Water Technologies, LLC business (June 2026). These provide recurring industrial water-treatment programmes (boilers, cooling towers, wastewater) to food & beverage, healthcare, manufacturing, data-centre and commercial/institutional customers. Licensing revenue is immaterial and not separately disclosed. ### Revenue model mix (indicative) ### Value chain position Kemira sits in the mid-stream of the chemical value chain. It purchases basic inputs and converts them into formulated or commodity-grade process chemicals. Inputs include iron and aluminium sources (including industrial by-products such as iron sulphate from steel and TiO2 production), acrylonitrile/acrylamide-based monomers (oil-derived), electricity (critical for sodium chlorate electrolysis), salt, and fatty acids for AKD. Approximately one-third of raw materials are oil-based and mainly used for polymer production (June 2026 investor newsletter). Kemira is backward-integrated in electricity in Finland through shareholdings in Pohjolan Voima and Teollisuuden Voima (Mankala principle: power at production cost). This is a key cost advantage for energy-intensive sodium chlorate production. ### Customer types and end-markets
Company Headquarters: Midland, US Founded: 1883 Workforce: ~98,000 Company Working: DowDuPont is a holding company that develops agricultural products, specialty materials, and chemicals. It operates through 534 manufacturing sites and the agriculture, performance materials and coatings, industrial intermediates and infrastructure, packaging and specialty plastics, electronics and imaging, nutrition and biosciences, transportation and advanced polymers, and safety and construction segments. DowDuPont planned to create three independent companies called Corteva Agriscience, Dow, and New DuPont, where Covetra Agriscience will represent the agriculture division of the company, while Dow will represent the materials science division, and New DuPont the specialty products division. In April 2019, DowDuPont completed separation of materials science division through the spin-off of Dow Inc and is likely to complete the separation of its agriculture division in June 2019.
Clariant is a mid-cap Swiss specialty chemical company that has spent a decade shrinking and upgrading itself. After selling Masterbatches (2020) and Pigments (2022) and exiting bioethanol (2023), it now runs three business units: Care Chemicals (54 % of 2025 sales), Catalysts (21 %) and Adsorbents & Additives (25 %). FY 2025 sales were CHF 3.915 billion with an EBITDA margin before exceptional items of 17.8 %, the third consecutive annual improvement. Its franchise rests on surfactant and ethoxylation chemistry for consumer and industrial formulators, a globally relevant independent process-catalyst business (CATOFIN propane dehydrogenation, syngas, ethylene and specialty catalysts), bentonite-based adsorbents with captive mines, and halogen-free flame retardants and waxes. SABIC holds 31.5 %, which anchors the register and limits free float. The investment debate turns on whether self-help can lift reported margins to the 19–21 % target by 2027 in a flat demand environment, and on a large, unresolved ethylene-cartel damages overhang. Discrepancy note: data aggregators (PitchBook, Morningstar) show 10 449 employees; the company's own year-end 2025 figure is 10 281 FTE. The company figure is used throughout. --- **What the company does.** Clariant develops, manufactures and sells specialty chemicals to formulators, industrial processors and chemical producers. It does not sell to consumers. The Integrated Report 2025 states that the Group mainly addresses consumer, industrial and chemical-process end markets and that, since January 2023, business is conducted through three business units. **Company's own description (paraphrased from 2025–2026 releases).** Clariant presents itself as a focused, sustainability-oriented specialty chemical company guided by the purpose "Greater chemistry – between people and planet", with strategy built on four pillars: customer focus, innovative chemistry, leadership in sustainability and people engagement. **Independent characterisation.** Clariant is a portfolio of three quite different economic models under one balance sheet: 1. Care Chemicals is a formulated-ingredient and surfactant business. A large share of volume is ethylene-oxide-derived chemistry (ethoxylates, polyethylene glycols, glucamides) sold into personal and home care, crop protection formulation, industrial applications, oil services, mining flotation and aircraft de-icing. Part of the industrial book is priced by formula against raw material indices, which stabilises unit margin but passes deflation through to the top line (visible in Q4 2025, when pricing fell 1 % for that reason). 2. Catalysts is a project-and-refill business. Revenue depends on new-build petrochemical plants (first fills) and on replacement cycles at existing customers, which stretch when customer utilisation is low. This produces lumpy quarters and high operating leverage. Catalysts had the highest BU margin in 2025 (20.8 % before exceptional items) on the lowest sales base in five years. 3. Adsorbents & Additives combines a mining-based minerals business (bentonite bleaching earths for edible oil and renewable-fuel purification, foundry additives, desiccants) with polymer additives (phosphorus flame retardants, waxes, stabilisers) exposed to construction, electronics, automotive and coatings. **Revenue model.** Essentially 100 % product sales. Service and licensing income exists but is not reported separately: technical service embedded in catalyst and oil-service contracts, the CLARITY digital catalyst-monitoring platform (over 220 customer plants and over 800 users in 38 countries at end-2025, per the FY 2025 release), and process-technology partnerships. There is no subscription revenue line. Product/service/licensing mix: not publicly disclosed. **Value-chain position.** Midstream. Clariant buys commodity feedstocks (ethylene oxide, fatty alcohols, natural oils, phosphorus derivatives, metals for catalysts, energy) and mines its own bentonite. It sells performance ingredients and catalysts where qualification, application know-how and regulatory approvals matter more than scale. **Customer types.** Consumer goods formulators, agrochemical companies, oil and gas operators, mining companies, airports and airlines, petrochemical and chemical producers, engineering and licensing partners, edible-oil and renewable-fuel refiners, foundries, plastics compounders, and coatings and adhesives producers. **End-market mix.** The Integrated Report 2024 gives chemical-process end markets as 21 % of 2024 sales.
12 interactive charts drawn from the Scale Inhibitors Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Scale Inhibitors Market Argentina, Mexico, Brazil and Rest Of South America
Global Scale Inhibitors Market Germany, Spain, France, United Kingdom, Italy, Poland, Russian Federation and Rest Of Europe By Country
Global Scale Inhibitors Market China, India, Japan, South Korea, Rest Of Asia Pacific and Asean Of Asia Pacific By Country
Global Scale Inhibitors Market United States and Canada Of North America By Country
Global Scale Inhibitors Market Rest Of Middle East And Africa, Turkey, Saudi Arabia, UAE and North-Africa Of Middle East And Africa
Global Scale Inhibitors Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Mn)
